Matches in SemOpenAlex for { <https://semopenalex.org/work/W4224108347> ?p ?o ?g. }
- W4224108347 endingPage "596" @default.
- W4224108347 startingPage "596" @default.
- W4224108347 abstract "(1) Background: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccines were developed in only a short amount of time and were widely distributed. We conducted this meta-analysis to understand the safety of SARS-CoV-2 vaccines. (2) Methods: We searched the corresponding literature published from 1 January 2020 to 20 October 2021. Information of adverse events (AEs) of each selected work was collected. The quality and bias of studies was evaluated, and meta-analysis was carried out by using Stata 17.0. (3) Results: Totally, 11,451 articles were retrieved, and 53 of them were included for analysis. The incidence rate of AEs was 20.05–94.48%. The incidence rate of vascular events increased after viral vector vaccination, while the incidence rate of vascular events decreased after mRNA vaccination. Viral vector vaccine had a higher AE rate compared to mRNA vaccines and inactivated vaccines. In most circumstances, the incidence of AEs was higher in older people, female and after the second dose. The sensitivity of meta-analysis was acceptable; however, the literature was subject to a certain publication bias. (4) Conclusions: The safety of SARS-CoV-2 vaccines was acceptable. The incidence of allergic symptoms and cardiovascular and cerebrovascular symptoms was low. Viral vector vaccine had a higher risk of leading to thrombosis events. The understanding of SARS-CoV-2 vaccine AEs should be enhanced, so as to promote the vaccination." @default.
- W4224108347 created "2022-04-19" @default.
- W4224108347 creator A5003934555 @default.
- W4224108347 creator A5023574591 @default.
- W4224108347 creator A5037509867 @default.
- W4224108347 creator A5041500959 @default.
- W4224108347 creator A5055838753 @default.
- W4224108347 creator A5058506093 @default.
- W4224108347 creator A5059447528 @default.
- W4224108347 creator A5070395523 @default.
- W4224108347 creator A5071222518 @default.
- W4224108347 creator A5079773727 @default.
- W4224108347 creator A5082848262 @default.
- W4224108347 date "2022-04-12" @default.
- W4224108347 modified "2023-10-17" @default.
- W4224108347 title "Safety of Global SARS-CoV-2 Vaccines, a Meta-Analysis" @default.
- W4224108347 cites W2118923346 @default.
- W4224108347 cites W2153972688 @default.
- W4224108347 cites W2518536270 @default.
- W4224108347 cites W3023016118 @default.
- W4224108347 cites W3028010531 @default.
- W4224108347 cites W3082011975 @default.
- W4224108347 cites W3111255098 @default.
- W4224108347 cites W3120968995 @default.
- W4224108347 cites W3125874619 @default.
- W4224108347 cites W3126621205 @default.
- W4224108347 cites W3127329393 @default.
- W4224108347 cites W3128551684 @default.
- W4224108347 cites W3128744331 @default.
- W4224108347 cites W3130815000 @default.
- W4224108347 cites W3131762051 @default.
- W4224108347 cites W3134019998 @default.
- W4224108347 cites W3137189552 @default.
- W4224108347 cites W3139490202 @default.
- W4224108347 cites W3142344243 @default.
- W4224108347 cites W3143941795 @default.
- W4224108347 cites W3145657260 @default.
- W4224108347 cites W3147435343 @default.
- W4224108347 cites W3152203705 @default.
- W4224108347 cites W3153281865 @default.
- W4224108347 cites W3153508314 @default.
- W4224108347 cites W3153536955 @default.
- W4224108347 cites W3153677448 @default.
- W4224108347 cites W3153840436 @default.
- W4224108347 cites W3153965330 @default.
- W4224108347 cites W3154242194 @default.
- W4224108347 cites W3154615775 @default.
- W4224108347 cites W3156509878 @default.
- W4224108347 cites W3156698571 @default.
- W4224108347 cites W3157453497 @default.
- W4224108347 cites W3157488589 @default.
- W4224108347 cites W3157545004 @default.
- W4224108347 cites W3158291028 @default.
- W4224108347 cites W3158339801 @default.
- W4224108347 cites W3158373340 @default.
- W4224108347 cites W3160085354 @default.
- W4224108347 cites W3161861537 @default.
- W4224108347 cites W3163349236 @default.
- W4224108347 cites W3164008218 @default.
- W4224108347 cites W3164069651 @default.
- W4224108347 cites W3164415613 @default.
- W4224108347 cites W3166101893 @default.
- W4224108347 cites W3167407382 @default.
- W4224108347 cites W3167953500 @default.
- W4224108347 cites W3168329104 @default.
- W4224108347 cites W3169082905 @default.
- W4224108347 cites W3170463273 @default.
- W4224108347 cites W3173050257 @default.
- W4224108347 cites W3176300313 @default.
- W4224108347 cites W3176625812 @default.
- W4224108347 cites W3176705561 @default.
- W4224108347 cites W3176961880 @default.
- W4224108347 cites W3177052412 @default.
- W4224108347 cites W3182460416 @default.
- W4224108347 cites W3186652499 @default.
- W4224108347 cites W3193768668 @default.
- W4224108347 cites W3200823719 @default.
- W4224108347 cites W3203248391 @default.
- W4224108347 cites W3210394608 @default.
- W4224108347 cites W3213552396 @default.
- W4224108347 cites W3216623344 @default.
- W4224108347 cites W4205483821 @default.
- W4224108347 cites W4205858893 @default.
- W4224108347 cites W4212781360 @default.
- W4224108347 cites W4301448958 @default.
- W4224108347 doi "https://doi.org/10.3390/vaccines10040596" @default.
- W4224108347 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35455344" @default.
- W4224108347 hasPublicationYear "2022" @default.
- W4224108347 type Work @default.
- W4224108347 citedByCount "14" @default.
- W4224108347 countsByYear W42241083472022 @default.
- W4224108347 countsByYear W42241083472023 @default.
- W4224108347 crossrefType "journal-article" @default.
- W4224108347 hasAuthorship W4224108347A5003934555 @default.
- W4224108347 hasAuthorship W4224108347A5023574591 @default.
- W4224108347 hasAuthorship W4224108347A5037509867 @default.
- W4224108347 hasAuthorship W4224108347A5041500959 @default.
- W4224108347 hasAuthorship W4224108347A5055838753 @default.